Deciphera Pharmaceuticals (DCPH) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free DCPH Stock Alerts $25.38 +0.01 (+0.04%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineZacks Research Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)americanbankingnews.com - May 6 at 3:34 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNKstockhouse.com - May 2 at 2:47 PMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Significant Decline in Short Interestamericanbankingnews.com - May 2 at 3:48 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Cut to "Market Perform" at Leerink Partnrsamericanbankingnews.com - May 2 at 1:46 AMBrokerages Set Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) PT at $23.87americanbankingnews.com - May 2 at 1:08 AMDECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPHbusinesswire.com - May 1 at 6:13 PMBarclays Upgrades Deciphera Pharmaceuticals (DCPH)msn.com - May 1 at 3:58 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Hits New 12-Month High at $25.03americanbankingnews.com - May 1 at 9:58 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Cut to Market Perform at Leerink Partnrsmarketbeat.com - May 1 at 7:42 AMDeciphera Pharmaceuticals' (DCPH) Market Perform Rating Reaffirmed at JMP Securitiesamericanbankingnews.com - May 1 at 5:40 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Receives "Neutral" Rating from Guggenheimamericanbankingnews.com - May 1 at 5:40 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Upgraded to "Equal Weight" at Barclaysamericanbankingnews.com - May 1 at 4:14 AMJefferies Downgrades Deciphera Pharmaceuticals (DCPH)msn.com - April 30 at 7:42 PMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Short Interest Down 5.1% in Aprilmarketbeat.com - April 30 at 6:47 PMDeep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)markets.businessinsider.com - April 30 at 2:38 PMJonesTrading Downgrades Deciphera Pharmaceuticals (DCPH)msn.com - April 30 at 2:38 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Sees Large Volume Increasemarketbeat.com - April 30 at 1:37 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Earns "Neutral" Rating from Guggenheimmarketbeat.com - April 30 at 1:31 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Rating Increased to Equal Weight at Barclaysmarketbeat.com - April 30 at 9:15 AMONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticalsfinance.yahoo.com - April 30 at 7:47 AMDeciphera Pharmaceuticals' (DCPH) Hold Rating Reaffirmed at Jefferies Financial Groupamericanbankingnews.com - April 30 at 6:02 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Receives "Hold" Rating from Jonestradingamericanbankingnews.com - April 30 at 6:02 AMJapan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansionreuters.com - April 30 at 3:44 AMINVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPHprnewswire.com - April 29 at 5:59 PMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Consensus Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - April 29 at 12:57 PMDeciphera to be acquired by Japanese drug firm for $2.4 billionmsn.com - April 29 at 11:45 AMUpdate: Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Dealfinance.yahoo.com - April 29 at 11:45 AMDeciphera Pharmaceuticals Is Being Acquired and the Stock Soars 72%finance.yahoo.com - April 29 at 11:45 AMJefferies Financial Group Reaffirms Hold Rating for Deciphera Pharmaceuticals (NASDAQ:DCPH)marketbeat.com - April 29 at 11:36 AMWhy Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?investorplace.com - April 29 at 10:33 AMShareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.prnewswire.com - April 29 at 10:30 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Reaches New 52-Week High at $25.03marketbeat.com - April 29 at 9:46 AMDeciphera Pharmaceuticals Is Being Acquired and the Stock Soars 71%barrons.com - April 29 at 9:01 AMDCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholdersbusinesswire.com - April 29 at 8:44 AMJapan's ONO Pharmaceutical to buy Deciphera for $2.4 billionreuters.com - April 29 at 7:08 AMDeciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billionbusinesswire.com - April 29 at 7:00 AMmarketbeat.com - April 29 at 6:57 AMDCPH Makes Notable Cross Below Critical Moving Averagenasdaq.com - April 27 at 5:37 AMAllspring Global Investments Holdings LLC Has $345,000 Stock Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - April 27 at 4:33 AMDiving Into Deciphera Pharmaceuticalsseekingalpha.com - April 26 at 3:56 PMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Significant Increase in Short Interestmarketbeat.com - April 17 at 11:16 AMDeciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forumbusinesswire.com - April 9 at 7:00 AMDeciphera Pharmaceuticals (NASDAQ:DCPH) Stock Price Down 3.6%marketbeat.com - April 8 at 3:24 PMSG Americas Securities LLC Lowers Stake in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - April 3 at 4:18 AMNovo Nordisk strikes deal worth up to $1.1 billion to expand cardio businessmsn.com - March 25 at 10:40 AMCompanies Like Deciphera Pharmaceuticals (NASDAQ:DCPH) Are In A Position To Invest In Growthfinance.yahoo.com - March 24 at 2:38 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Given New $16.00 Price Target at JPMorgan Chase & Co.marketbeat.com - March 21 at 2:52 PMDeciphera Pharmaceuticals (NASDAQ:DCPH) Shares Down 5.1% marketbeat.com - March 18 at 12:44 PMDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Sold by Jacobs Levy Equity Management Inc.marketbeat.com - March 13 at 6:56 AMHsbc Holdings PLC Has $237,000 Stock Holdings in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)marketbeat.com - March 10 at 4:43 AM Get Deciphera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here DCPH Media Mentions By Week DCPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DCPH News Sentiment▼0.130.38▲Average Medical News Sentiment DCPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DCPH Articles This Week▼153▲DCPH Articles Average Week Get Deciphera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRVI News Today TGTX News Today KROS News Today AMPH News Today GERN News Today VERA News Today ARVN News Today DYN News Today RCKT News Today NAMS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DCPH) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBiden replacement revealed?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon Musk Secret Crypto Plot ExposedCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
